Ttbio Corp.

Taipei Exchange 6493.TWO

Ttbio Corp. Capital Expenditure for the year ending December 31, 2023: USD -1.41 M

Ttbio Corp. Capital Expenditure is USD -1.41 M for the year ending December 31, 2023, a -4.55% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Ttbio Corp. Capital Expenditure for the year ending December 31, 2022 was USD -1.35 M, a -124.26% change year over year.
  • Ttbio Corp. Capital Expenditure for the year ending December 31, 2021 was USD -600.70 K, a 4.14% change year over year.
  • Ttbio Corp. Capital Expenditure for the year ending December 31, 2020 was USD -626.68 K, a 37.70% change year over year.
  • Ttbio Corp. Capital Expenditure for the year ending December 31, 2019 was USD -1.01 M.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Taipei Exchange: 6493.TWO

Ttbio Corp.

CEO Shu Rong Yang
IPO Date Jan. 8, 2015
Location
Headquarters No. 07, 6th Road Industry Park
Employees 101
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email